**PURPOSE:** Although postoperative antibiotic prophylaxis (PAP) is thought to minimize the risk of infection after implant-based reconstruction, the efficacy of this practice remains unclear. The goal of this study was to determine whether PAP effectively prevents failure of immediate prosthesis-based breast reconstruction due to infection.

**METHODS:** Using Truven MarketScan data, we identified all patients who underwent immediate reconstruction between 2009--2013 with at least 6 months of follow-up. PAP included any oral antibiotic prescription filled within 7 days prior to surgery through 24 hours post-discharge. The primary outcomes were infection and explantation due to infection. Multivariable regression analyses controlled for demographic variables and comorbidities.

**RESULTS:** Of the 10,784 patients who underwent immediate prosthesis-based reconstruction, 5,516 (51%) filled antibiotic prescriptions. These patients were equally likely to develop an infection (OR 1.0 95%CI(0.85--1.18); p=0.98) or require explantation (OR 0.96 95%CI(0.80--1.15); p=0.64) compared to those who did not. There was no difference in the likelihood of infection or explantation based on duration of antibiotics of 1--5 days (OR 0.85 95%CI(0.59--1.08); p=0.08), 6--10 days (OR 1.01 95%CI(0.90--1.14); p=0.84), or greater than 10 days (OR 0.97 95%CI(0.81--1.16); p=0.74). Comorbidities significantly increased the risk of infection and explantation (p\<.05).

**CONCLUSION:** In this population-based study, PAP did not reduce the risk of infection following prosthesis-based reconstruction. Given rising rates of antibiotic resistance, focusing on management of comorbid conditions may be more valuable.
